[Consideration of cancer home chemotherapy with cooperation between hospital and clinic].
Recently, the progress in chemotherapy has brought an improvement in the survival rate of patients with non-resectable digestive tract cancer. Simultaneously, maintenance of patients' QOL is regarded as important. In our hospital, we use low-dose FP therapy to maintain QOL and a satisfactory survival rate. To date, we have administered low-dose FP to more than 50 patients with non-resectable digestive cancer. We investigated patients who received home chemotherapy after being evaluated NC, and found no remarkable side effects as a result of this therapy during admission.
Muto
Y
Y
Dept. of Gastroenterology, Jizankai Medical Foundation, Tsuboi Cancer Center Hospital.
Takebuchi
K
K
Watanabe
M
M
Hasegawa
K
K
Sakonji
M
M
Matsukawa
M
M
Kurihara
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003299:Cooperative Behavior; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage; D018575:Home Care Services, Hospital-Based; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011788:Quality of Life; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil; D002945:Cisplatin; D005472:Fluorouracil